Humanin vs NAD+
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: HN, HNG (S14G-humanin)
Humanin is a 24-amino-acid peptide encoded inside mitochondrial DNA (in the 16S rRNA gene), discovered in 2001 and named for its ability to protect human neurons from Alzheimer-related cell death. It was the first member of the mitochondrial-derived peptide family and is studied mainly for neuroprotection, cell survival, and metabolic and age-related disease. The honest status: it has the deepest preclinical evidence base of any mitochondrial peptide, but human therapeutic trials are essentially absent.
Also: Nicotinamide Adenine Dinucleotide, NAD
NAD+ is not a peptide at all, it is a coenzyme every cell uses to move electrons around during energy production. It gets grouped with peptides because it is sold in the same places and injected the same way. Levels fall with age, which is the entire basis of the longevity interest, but the leap from that observation to injecting it is longer than most sellers admit.
Key Comparison Insights
- Both peptides belong to the Anti-Aging category, suggesting similar primary applications.
- NAD+ has stronger research evidence (Human Trials) compared to Humanin (Animal Studies).
Detailed Comparison
| Attribute | Humanin | NAD+ |
|---|---|---|
| Category | Anti-Aging | Anti-Aging |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Humanin is fundamentally a cell-survival signal that blocks apoptosis, the programmed self-destruct cells run when stressed. It binds a trimeric receptor complex made of CNTFR, WSX-1, and gp130 on the cell surface, switching on JAK2/STAT3 survival signaling. Inside the cell it directly grabs the pro-apoptotic protein BAX and stops it from moving to the mitochondria and punching holes in the membrane, which is the step that would otherwise commit the cell to death. It also binds IGFBP-3, modulating IGF-1 signaling and further dialing down apoptosis, and it interacts with formyl peptide receptors. The throughline across all of these is the same: keep stressed cells alive and protect mitochondria. | NAD+ is a required cofactor in the reactions that turn food into ATP, and it is consumed as a substrate by two families of enzymes tied to ageing: sirtuins, which regulate DNA repair and metabolic signalling, and PARPs, which repair DNA damage. Because NAD+ is used up by these processes, sustained DNA damage or metabolic stress can deplete it. The theory is that restoring NAD+ restores the function of everything downstream. The unresolved problem is delivery: NAD+ is a large charged molecule that does not readily cross cell membranes, which is why most serious research uses precursors like nicotinamide riboside or NMN that cells can actually take up and convert internally. |
| Common Dosing | 5-10 mg weekly divided into 2-3 injections 2-3x weekly (e.g., Monday, Wednesday, Friday) | 50-100 mg subcutaneous, 2-3x weekly Two to three times weekly, or per clinic protocol for IV |
| Administration | Injection (route varies) | Subcutaneous injection or slow IV infusion. Fast infusion is the main cause of the flushing and chest tightness people report. |
| Typical Duration | Variable | Ongoing use is common. No controlled long-term injectable data exists. |
| Best Time to Take | Morning | Morning |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Humanin is one of the best-characterized mitochondrial peptides in the lab, with a large body of in vitro and animal work. It protects neurons against amyloid-beta toxicity, shields retinal pigment epithelium cells from oxidative stress and senescence, and shows protective effects in models of cardiovascular disease and diabetes. Circulating humanin declines with age in humans, and some studies link higher endogenous levels to better metabolic and longevity markers, which fuels the longevity interest. But that is association and animal data, not proof that taking humanin treats any disease. There are no large completed randomized human trials demonstrating clinical benefit, and most of what is sold to consumers is synthetic humanin or analogues like HNG, used far ahead of the evidence. It is a compelling research molecule, not a validated drug. | The decline of NAD+ with age is well documented, and precursor supplementation reliably raises blood NAD+ levels in human trials. What those trials have not clearly shown is that raising NAD+ produces the functional benefits people are hoping for. Human studies on nicotinamide riboside and NMN show good safety and consistent biomarker changes, with inconsistent effects on measurable outcomes like muscle function, insulin sensitivity or fatigue. Direct injected or infused NAD+ has far thinner evidence than the precursors do: most of what exists is small, uncontrolled, or observational, and the widely reported subjective effects of IV NAD+ have not been separated from placebo in good trials. Anyone telling you injected NAD+ has strong human evidence is describing the precursor literature and attaching it to a different product. |
Frequently Asked Questions: Humanin vs NAD+
What is the difference between Humanin and NAD+?
Humanin is a anti-aging peptide that humanin is a 24-amino-acid peptide encoded inside mitochondrial dna (in the 16s rrna gene), discovered in 2001 and named for its ability to protect human neurons from alzheimer-related cell death. it was the first member of the mitochondrial-derived peptide family and is studied mainly for neuroprotection, cell survival, and metabolic and age-related disease. the honest status: it has the deepest preclinical evidence base of any mitochondrial peptide, but human therapeutic trials are essentially absent. NAD+ is a anti-aging peptide that nad+ is not a peptide at all, it is a coenzyme every cell uses to move electrons around during energy production. it gets grouped with peptides because it is sold in the same places and injected the same way. levels fall with age, which is the entire basis of the longevity interest, but the leap from that observation to injecting it is longer than most sellers admit. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Humanin or NAD+?
Neither is universally "better" - the choice depends on your specific goals. Humanin is typically used for anti-aging purposes, while NAD+ is used for anti-aging. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Humanin and NAD+ be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Humanin and NAD+ together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.